The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 294K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haughn, L.
Right arrow Articles by Julius, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haughn, L.
Right arrow Articles by Julius, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/11/1575/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 9, November 2, 1998 1575-1586


Articles

Interleukin 2–mediated Uncoupling of T Cell Receptor {alpha}/β from CD3 Signaling

Loralee Haughn*, Bernadine Leung{ddagger}, Lawrence Boise§, André Veillette||, Craig Thompson, and Michael Julius{ddagger}

From the * Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada H3A 2B4; the {ddagger} Department of Immunology, University of Toronto, and The Arthritis and Immune Disorder Research Center, Toronto, Ontario, Canada M5G 2M9; the § Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida 33101; the || McGill Cancer Centre and the Departments of Biochemistry, Medicine, and Oncology, McGill University, Montreal, Quebec, Canada H3G 1Y6; and the Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois 60637

T cell activation and clonal expansion is the result of the coordinated functions of the receptors for antigen and interleukin (IL)-2. The protein tyrosine kinase p56lck is critical for the generation of signals emanating from the T cell antigen receptor (TCR) and has also been demonstrated to play a role in IL-2 receptor signaling. We demonstrate that an IL-2–dependent, antigen-specific CD4+ T cell clone is not responsive to anti-TCR induced growth when propagated in IL-2, but remains responsive to both antigen and CD3{varepsilon}-specific monoclonal antibody. Survival of this IL-2–dependent clone in the absence of IL-2 was supported by overexpression of exogenous Bcl-xL. Culture of this clonal variant in the absence of IL-2 rendered it susceptible to anti-TCR–induced signaling, and correlated with the presence of kinase-active Lck associated with the plasma membrane. The same phenotype is observed in primary, resting CD4+ T cells. Furthermore, the presence of kinase active Lck associated with the plasma membrane correlates with the presence of ZAP 70–pp21{zeta} complexes in both primary T cells and T cell clones in circumstances of responsive anti-TCR signaling. The results presented demonstrate that IL-2 signal transduction results in the functional uncoupling of the TCR complex through altering the subcellular distribution of kinase-active Lck.

Key Words: Lck • kinase • interleukin 2 • regulation


Address correspondence to Michael Julius, Arthritis and Immune Disorder Research Centre, Suite 700, 620 University Ave., c/o 610 University Ave., Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-6549; Fax: 416-946-6589; E-mail: michael.julius{at}utoronto.ca

L. Haughn was supported by a fellowship from the Cancer Research Society, Inc. B. Leung was supported by a Medical Research Council studentship. A. Veillette is the recipient of an MRC Scientist Award. This work was supported by grants from the Medical Research Council of Canada, the National Cancer Institute, and the National Institutes of Health.

L. Haughn and B. Leung contributed equally to this paper.

Abbreviations used: HMF, heavy membrane fraction; HRP, horseradish peroxidase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS